Get the Stockscreener App
3.10
2.65%
0.08
Pre-market:
3.02
-0.08
-2.58%
Nrx Pharmaceuticals Inc stock is traded at $3.10, with a volume of 1.09M.
It is up +2.65% in the last 24 hours and down -6.06% over the past month.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
See More
Previous Close:
$3.02
Open:
$3.07
24h Volume:
1.09M
Relative Volume:
2.42
Market Cap:
$61.41M
Revenue:
-
Net Income/Loss:
$-30.15M
P/E Ratio:
-0.775
EPS:
-4
Net Cash Flow:
$-21.66M
1W Performance:
-1.59%
1M Performance:
-6.06%
6M Performance:
+46.23%
1Y Performance:
+126.28%
1-Day Range:
$3.00
$3.38
1-Week Range:
$2.91
$3.38
52-Week Range:
$1.12
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Name
Nrx Pharmaceuticals Inc
Sector
Industry
Phone
484-254-6134
Address
1201 ORANGE STREET, WILMINGTON
Compare NRXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
3.10 | 71.79M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | H.C. Wainwright | Buy |
| Apr-02-25 | Initiated | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Stock (NRXP) Latest News
Is NRx Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Movers & Real-Time Volume Analysis Alerts - newser.com
Risk adjusted return profile for NRx Pharmaceuticals Inc. Equity Warrant analyzedWeekly Stock Report & Risk Controlled Swing Alerts - newser.com
Can NRx Pharmaceuticals Inc. stock hit record highs againJuly 2025 PostEarnings & Community Consensus Trade Alerts - newser.com
Is now a turning point for NRx Pharmaceuticals Inc. Equity WarrantFed Meeting & High Return Stock Watch Alerts - newser.com
Will NRx Pharmaceuticals Inc. stock recover faster than peersJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - newser.com
Analyzing drawdowns of NRx Pharmaceuticals Inc. with statistical tools2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
Using AI based signals to follow NRx Pharmaceuticals Inc.2025 Trading Recap & Growth Focused Entry Reports - newser.com
Why NRx Pharmaceuticals Inc. Equity Warrant stock appeals to analystsTrade Analysis Report & Daily Growth Stock Investment Tips - newser.com
Using fundamentals and technicals on NRx Pharmaceuticals Inc.Trade Performance Summary & Verified Swing Trading Watchlists - newser.com
Why NRx Pharmaceuticals Inc. stock remains resilientPortfolio Growth Summary & High Accuracy Trade Alerts - newser.com
Market reaction to NRx Pharmaceuticals Inc.’s recent newsJuly 2025 Movers & Weekly High Return Opportunities - newser.com
How to track smart money flows in NRx Pharmaceuticals Inc.July 2025 Outlook & Consistent Profit Alerts - newser.com
Is it time to cut losses on NRx Pharmaceuticals Inc.2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Pattern recognition hints at NRx Pharmaceuticals Inc. upsideQuarterly Market Summary & Consistent Growth Stock Picks - newser.com
Using AI based signals to follow NRx Pharmaceuticals Inc. Equity WarrantMarket Movement Recap & Risk Controlled Swing Trade Alerts - newser.com
What indicators show strength in NRx Pharmaceuticals Inc. Equity Warrant2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com
Will NRx Pharmaceuticals Inc. Equity Warrant stock recover faster than marketQuarterly Trade Report & Fast Moving Stock Watchlists - newser.com
Visual trend scoring systems applied to NRx Pharmaceuticals Inc.Weekly Trend Recap & Comprehensive Market Scan Insights - newser.com
What candlestick patterns are forming on NRx Pharmaceuticals Inc. Equity WarrantJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Real time breakdown of NRx Pharmaceuticals Inc. stock performanceJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
Using RSI to spot recovery in NRx Pharmaceuticals Inc.July 2025 EndofMonth & Safe Capital Growth Tips - newser.com
New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine - Tallahassee Democrat
Ascendiant Capital Markets Boosts NRx Pharmaceuticals (NASDAQ:NRXP) Price Target to $47.00 - MarketBeat
Published on: 2025-10-31 06:02:01 - newser.com
Using data models to predict NRx Pharmaceuticals Inc. stock movementSell Signal & Daily Oversold Stock Bounce Ideas - newser.com
Why analysts upgrade NRx Pharmaceuticals Inc. Equity Warrant stockWeekly Trend Recap & High Conviction Buy Zone Alerts - newser.com
Applying Wyckoff theory to NRx Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Short Interest & AI Powered Market Entry Ideas - newser.com
Detecting support and resistance levels for NRx Pharmaceuticals Inc.Market Performance Report & Verified Short-Term Trading Plans - newser.com
Nrx Pharmaceuticals Inc Stock (NRXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):